Lymphocyte morphology in a patient receiving CD19 chimeric antigen receptor T‐cell therapy for mantle cell lymphoma

Lymphocyte morphology in a patient receiving CD19 chimeric antigen receptor T‐cell therapy for mantle cell lymphoma

Bibliographic Details
Main Authors:	Maria A. V. Marzolini, Lorna Neill, Maeve O'Reilly, Karl S. Peggs, Claire Roddie
Format:	Article
Language:	English
Published:	Wiley 2022-02-01
Series:	eJHaem
Online Access:	https://doi.org/10.1002/jha2.334

Similar Items

High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T‐cell therapy for large B‐cell lymphoma
by: Maeve A. O'Reilly, et al.
Published: (2024-01-01)

Chimeric antigen receptor (CAR) T-cell treatment for mantle cell lymphoma (MCL)
by: Bushra Tbakhi, et al.
Published: (2022-02-01)

P1151: BENDAMUSTINE-CONTAINING REGIMENS CAN BE SAFELY USED AS BRIDGING IN LARGE B-CELL LYMPHOMA PATIENTS RECEIVING CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY
by: Gloria Ines Iacoboni Garcia-Calvo, et al.
Published: (2023-08-01)

Cellular Therapeutic Approaches to Cytomegalovirus Infection Following Allogeneic Stem Cell Transplantation
by: Manar S. Shafat, et al.
Published: (2020-07-01)

The role of B cell antigen receptors in mantle cell lymphoma
by: Michael Fichtner, et al.
Published: (2017-10-01)

Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas
by: Michael Green, et al.
Published: (2023-11-01)

Benefits of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma
by: Wenyujing Zhou, et al.
Published: (2022-01-01)

Chimeric Antigen Receptor T Cells Targeting CD19 and Ibrutinib for Chronic Lymphocytic Leukemia
by: Julio Delgado, et al.
Published: (2019-04-01)

Large-scale manufacturing of base-edited chimeric antigen receptor T cells
by: Rosie Woodruff, et al.
Published: (2023-12-01)

Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy following anti‐CD19 CAR‐T therapy: a case report
by: Strachan Mackenzie, et al.
Published: (2021-11-01)

Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
by: Yixin Zou, et al.
Published: (2018-11-01)

Chimeric Antigen Receptor (CAR)-T Cell Therapy for Non-Hodgkin’s Lymphoma
by: Maria Giraudo, et al.
Published: (2024-03-01)

Research Progress of Chimeric Antigen Receptor NK Cells in Treatment of Lymphoma
by: HU Run, et al.
Published: (2023-12-01)

P1459: SAFETY AND EFFICACY FINDINGS OF AUTO1, A FAST-OFF RATE CD19 CAR, IN RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA (B-NHL), AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) / SMALL LYMPHOCYTIC LYMPHOMA (SLL)
by: C. Roddie, et al.
Published: (2022-06-01)

Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
by: Zixun Yin, et al.
Published: (2021-07-01)

Relevance of gene signatures in differential diagnosis of mantle cell and B-cell chronic lymphocytic lymphoma
by: G Hemamalini, et al.
Published: (2010-01-01)

Cytogenetics of mantle cell lymphoma
by: T N Obukhova, et al.
Published: (2004-07-01)

Role of Radiation in Combination With CD30-Directed Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Hodgkin Lymphoma
by: Colton Ladbury, MD, et al.
Published: (2024-04-01)

The Role of CD200 and CD43 Expression in Differential Diagnosis between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
by: Mesude Falay, et al.
Published: (2018-05-01)

Chimeric Antigen Receptor-T Cell Therapy for Lymphoma: New Settings and Future Directions
by: Corrado Benevolo Savelli, et al.
Published: (2023-12-01)

Cytopenia after chimeric antigen receptor T cell immunotherapy in relapsed or refractory lymphoma
by: Jin Zhou, et al.
Published: (2022-09-01)

Pre-clinical efficacy of CD20-targeted chimeric antigen receptor T cells for non-Hodgkin's lymphoma
by: Hairuo Wen, et al.
Published: (2022-11-01)

A critical appraisal of ibrutinib in the treatment of mantle cell lymphoma and chronic lymphocytic leukemia
by: Tucker DL, et al.
Published: (2015-06-01)

Prognostic value of prelymphodepletion absolute lymphocyte counts in relapsed/refractory diffuse large B-cell lymphoma patients treated with chimeric antigen receptor T cells
by: Yanyan Lu, et al.
Published: (2023-05-01)

Chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma: opportunities and challenges
by: Shinichi Makita, et al.
Published: (2019-02-01)

CAR T-cell therapy for follicular lymphoma and mantle cell lymphoma
by: Razan Mohty, et al.
Published: (2022-12-01)

P1081: A MULTICENTER OBSERVATIONAL STUDY ON CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOR LARGE B-CELL (LBCL) AND MANTLE CELL (MCL) LYMPHOMAS: THE ITALIAN CART-SIE REAL LIFE EXPERIENCE
by: Annalisa Chiappella, et al.
Published: (2023-08-01)

Tackling Mantle Cell Lymphoma in Europe
by: Denis Horgan, et al.
Published: (2022-09-01)

Primary gastric mantle cell lymphoma
by: Duska Petranovic, et al.
Published: (2012-01-01)

Educational Case: Mantle Cell Lymphoma
by: Brenda Mai MD, et al.
Published: (2020-07-01)

Diagnosis and treatment of mantle cell lymphoma
by: Felicitas Hitz, et al.
Published: (2013-11-01)

Emerging therapies in mantle cell lymphoma
by: Walter Hanel, et al.
Published: (2020-06-01)

Mantle Cell Lymphoma Case Report
by: V.I. Podzolkov, et al.
Published: (2018-12-01)

cutaneous manifestation of mantle cell lymphoma
by: avinash kumar singh, et al.
Published: (2014-08-01)

Chimeric Antigen Receptor-Modified T Cell Immunotherapy for Relapsed and Refractory Adult Burkitt Lymphoma
by: Jiaying Wu, et al.
Published: (2022-05-01)

P1236: EFFICACY AND TOXICITY FOR CD7 CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY T-CELL LYMPHOMA
by: K. Hu, et al.
Published: (2022-06-01)

Humanized CD30-Targeted Chimeric Antigen Receptor T Cells Exhibit Potent Preclinical Activity Against Hodgkin’s Lymphoma Cells
by: Jing Guo, et al.
Published: (2022-01-01)

Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study
by: Lucia Morello, et al.
Published: (2020-02-01)

A decade of CD4+ chimeric antigen receptor T-cell evolution in two chronic lymphocytic leukemia patients: were chronic lymphocytic leukemia cells present?
by: Dimitrios Bouzianas, et al.
Published: (2023-10-01)

Indicators describing the tumor lesion aggregation and dissemination and their impact on the prognosis of patients with diffuse large B cell lymphoma receiving chimeric antigen receptor T cell therapy
by: Xiuyong Dang, et al.
Published: (2024-03-01)